Comparison of faecal and intestinal concentrations of granulocyte marker protein and localization of gastrointestinal tumours in rats

Scandinavian Journal of Gastroenterology

Volumn 37, Issue 9, 2002, Pages 1029-1033

  Kristinsson, Jon ^a   Nygaard, K ^a   Sundseth, A ^a   Aadland, E ^a   Fagerhol, M K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Azoxymethane; Calprotectin; Experimental carcinomas in rats; Granulocyte marker protein; Polymorphonuclear leukocytes

Indexed keywords

AZOXYMETHANE; GRANULOCYTE MARKER PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCENDING COLON; CARCINOGENESIS; COLON ADENOMA; COLON CARCINOMA; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DESCENDING COLON; FECES LEVEL; GASTROINTESTINAL TUMOR; INFLAMMATION; INTESTINE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE CARCINOMA; SMALL INTESTINE TUMOR; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADENOMA; ANIMALS; AZOXYMETHANE; CARCINOGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; GASTROINTESTINAL NEOPLASMS; INTESTINAL MUCOSA; LEUKOCYTE L1 ANTIGEN COMPLEX; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; TUMOR MARKERS, BIOLOGICAL;

EID: 0036743371     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655202320378211     Document Type: Article

References (26)

1. Roseth AG, Kristinsson J, Fagerhol MK, Schjonsby H, Aadland E, Nygaard K, et al. Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol 1993;28:1073-6.
2. Kronborg O, Ugstad M, Fuglerud P, Johne B, Hardcastle J, Scholefield JH, et al. Faecal calprotectin levels in a high risk population for colorectal neoplasia. Gut 2000;46:795-800.
3. Kristinsson J, Roseth A, Fagerhol MK, Aadland E, Schjonsby H, Bormer OP, et al. Fecal calprotectin concentration in patients with colorectal carcinoma. Dis Colon Rectum 1998;41:316-21.
4. Santos J, Saperas E, Nogueiras C, Mourelle M, Antolin M, Cadahia A, et al. Release of mast cell mediators into the jejunum by cold pain stress in humans. Gastroenterology 1998;114:640-8.
5. Roseth AG, Fagerhol MK, Foster R, Sundset AT, Peters TJ, Bjarnason I. Isolation, purification and assessment for transferrin as a granulocyte marker protein (GMP) in rats; temporal relationship between intestinal permeability and inflammation in NSAID enteropathy. In: Dept. of Medicine Aker University Hospital and Dept. of Immunology and Transfusion Medicine Ullevaal Univerity Hospital, Oslo, University of Oslo, 1999. p. 70.
6. Huebers H, Huebers E, Rummel W, Crichton RR. Isolation and characterization of iron-binding proteins from rat intestinal mucosa. Eur J Biochem 1976;66:447-55.
7. Borregaard N, Kjeldsen L, Rygaard K, Bastholm L, Nielsen MH, Sengelov H, et al. Stimulus-dependent secretion of plasma proteins from human neutrophils. J Clin Invest 1992;90:86-96.
8. Evans WH, Wilson SM, Mage MG. Transferrin induces maturation of neutrophil granulocyte precursors in vitro. Leukemia Res 1986;10:429-36.
9. Sakamoto H, Sakamoto N, Oryu M, Kobayashi T, Ogawa Y, Ueno M, et al. A novel function of transferrin as a constituent of macromolecular activators of phagocytosis from platelets and their precursors. Biochem Biophys Res Commun 1997;230:270-4.
10. Mackay JA, Sass-Kuhn S, Moqbel R, Walsh GM, Kay AB. The requirements for transferrin-dependent adherence of human granulocytes to pollen grains. Allergy 1986;41:169-78.
11. Ward JM, Yamamoto RS, Brown CA. Pathology of intestinal neoplasms and other lesions in rats exposed to azoxymethane. J Natl Cancer Inst 1973;51:1029-39.
12. Kristinsson J, Roseth AG, Sundset A, Nygaard K, Loberg EM, Paulsen JE, et al. Granulocyte marker protein is increased in stools from rats with azoxymethane-induced colon cancer. Scand J Gastroenterol 1999;34:1216-23.
13. Sobin LH. Histological typing of intestinal tumours, 2nd ed. Berlin: Springer-Verlag.
14. Hermanek PSLH. TNM classification of malignant tumours, 4th ed. Berlin, Heidelberg, New York, London, Paris, Tokyo, Hong Kong, Barcelona, Budapest, Springer-Verlag; 1992.
15. Roseth AG, Fagerhol MK, Aadland E, Schjonsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992;27:793-8.
16. Putnam FW, Roop WE. Purification and characterization of genetic variants of human transferrins. Bibl Haematol 1965;23:1178-80.
17. MacGillivray RT, Mendez E, Sinha SK, Sutton MR, Lineback-Zins J, Brew K. The complete amino acid sequence of human serum transferrin. Proceedings of the National Academy of Sciences of the United States of America 1982;79:2504-8.
18. Schumann K, Elsenhans B, Forth W. On the origin of intestinal transferrin. Res Exp Med 1988;188:67-77.
19. Barnes D, Sato G. Serum-free cell culture: a unifying approach. Cell 1980;22:649-55.
20. de Jong G, van Dijk JP, van Eijk HG. The biology of transferrin. Clin Chim Acta 1990;190:1-46.
21. Idzerda RL, Huebers H, Finch CA, McKnight GS. Rat transferrin gene expression: tissue-specific regulation by iron deficiency. Proceedings of the National Academy of Sciences of the United States of America 1986;83:3723-7.
22. Regoeczi E, Chindemi PA. Translocation of different forms of transferrin from blood to bile in the rat. Hepatology 1995;21:1063-9.
23. Regoeczi E, Chindemi PA, Hu WL. Transport of lactoferrin from blood to bile in the rat. Hepatology 1994;19:1476-82.
24. Mugitani K. [Detection of transferrin in the digestive juices of rat and its possible role in iron absorption from the small intestine]. Nippon Ika Daigaku Zasshi - J Nippon Med School 1989;56:144-52.
25. Eue I, Pietz B, Storck J, Klempt M, Sorg C. Transendothelial migration of 27E10+ human monocytes. Int Immunol 2000;12:1593-604.
26. Bjarnason I, Peters TJ. Intestinal permeability, non-steroidal anti-inflammatory drug enteropathy and inflammatory bowel disease: an overview. Gut 1989;30 Spec. No. 22-8.